Dimensional Fund Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7M Buy
1,352,329
+122,718
+10% +$2.2M ﹤0.01% 1907
2025
Q4
$19.7M Buy
1,229,611
+118,535
+11% +$1.76M ﹤0.01% 1973
2025
Q3
$13.7M Sell
1,111,076
-58,392
-5% -$685K ﹤0.01% 2177
2025
Q2
$13.5M Buy
1,169,468
+196,907
+20% +$2.34M ﹤0.01% 2151
2025
Q1
$14.6M Buy
972,561
+124,578
+15% +$2.09M ﹤0.01% 2088
2024
Q4
$14.7M Buy
847,983
+28,393
+3% +$548K ﹤0.01% 2147
2024
Q3
$15.2M Buy
819,590
+67,436
+9% +$1.35M ﹤0.01% 2121
2024
Q2
$15.3M Sell
752,154
-56,361
-7% -$997K ﹤0.01% 2089
2024
Q1
$13.8M Sell
808,515
-139,292
-15% -$2.19M ﹤0.01% 2173
2023
Q4
$16.7M Buy
947,807
+75,684
+9% +$1.52M ﹤0.01% 2079
2023
Q3
$20.9M Buy
872,123
+58,408
+7% +$1.43M 0.01% 1892
2023
Q2
$18.9M Buy
813,715
+20,689
+3% +$468K 0.01% 1960
2023
Q1
$17.5M Buy
793,026
+240,452
+44% +$5.63M 0.01% 1976
2022
Q4
$11.2K Buy
552,574
+42,949
+8% +$833K ﹤0.01% 2149
2022
Q3
$6.87M Sell
509,625
-100,400
-16% -$1.69M ﹤0.01% 2309
2022
Q2
$12.1M Buy
610,025
+99,748
+20% +$2.65M ﹤0.01% 2118
2022
Q1
$16.1M Buy
510,277
+66,137
+15% +$1.85M 0.01% 2081
2021
Q4
$9.91M Buy
444,140
+1,019
+0.2% +$26.6K ﹤0.01% 2311
2021
Q3
$12.3M Sell
443,121
-306,977
-41% -$9.34M ﹤0.01% 2233
2021
Q2
$29.2M Buy
750,098
+23,005
+3% +$825K 0.01% 1853
2021
Q1
$20.9M Buy
727,093
+92,651
+15% +$3.17M 0.01% 2012
2020
Q4
$16.8M Buy
634,442
+29,875
+5% +$610K 0.01% 2063
2020
Q3
$9.23M Sell
604,567
-3,729
-0.6% -$78.2K ﹤0.01% 2232
2020
Q2
$12.4M Sell
608,296
-80,467
-12% -$1.44M 0.01% 2119
2020
Q1
$7.12M Buy
688,763
+38,503
+6% +$1.08M ﹤0.01% 2265
2019
Q4
$24.5M Buy
650,260
+119,016
+22% +$5.35M 0.01% 1934
2019
Q3
$24.8M Buy
531,244
+90,316
+20% +$4.2M 0.01% 1883
2019
Q2
$23.1M Buy
440,928
+13,909
+3% +$816K 0.01% 1972
2019
Q1
$29.4M Buy
427,019
+29,169
+7% +$1.96M 0.01% 1841
2018
Q4
$23.7M Buy
397,850
+98,124
+33% +$8.47M 0.01% 1895
2018
Q3
$34.7M Buy
299,726
+4,620
+2% +$521K 0.01% 1779
2018
Q2
$37.2M Buy
295,106
+17,914
+6% +$2.18M 0.01% 1711
2018
Q1
$30M Buy
277,192
+8,287
+3% +$917K 0.01% 1816
2017
Q4
$29.5M Buy
268,905
+10,117
+4% +$1.01M 0.01% 1839
2017
Q3
$25.5M Sell
258,788
-1,704
-0.7% -$165K 0.01% 1893
2017
Q2
$26.4M Buy
260,492
+7,077
+3% +$763K 0.01% 1844
2017
Q1
$29.3M Buy
253,415
+35,745
+16% +$4.15M 0.01% 1721
2016
Q4
$26.1M Buy
217,670
+6,962
+3% +$771K 0.01% 1782
2016
Q3
$23.7M Buy
210,708
+16,797
+9% +$1.93M 0.01% 1778
2016
Q2
$24M Buy
193,911
+2,500
+1% +$302K 0.01% 1693
2016
Q1
$21.5M Sell
191,411
-3,560
-2% -$370K 0.01% 1758
2015
Q4
$21.2M Sell
194,971
-5,193
-3% -$594K 0.01% 1731
2015
Q3
$20M Buy
200,164
+46,019
+30% +$5.01M 0.01% 1754
2015
Q2
$17.6M Buy
154,145
+86,622
+128% +$10.5M 0.01% 1944
2015
Q1
$7.05M Sell
67,523
-229
-0.3% -$24.4K ﹤0.01% 2408
2014
Q4
$8.15M Buy
67,752
+3,464
+5% +$455K 0.01% 2363
2014
Q3
$9.41M Buy
64,288
+100
+0.2% +$15.4K 0.01% 2240
2014
Q2
$10.7M Buy
64,188
+23,695
+59% +$4.22M 0.01% 2172
2014
Q1
$8.04M Buy
40,493
+5,985
+17% +$1.13M 0.01% 2322
2013
Q4
$6.59M Buy
34,508
+1,496
+5% +$278K 0.01% 2433
2013
Q3
$5.58M Buy
33,012
+9,731
+42% +$1.51M ﹤0.01% 2488
2013
Q2
$3.53M Buy
+23,281
New +$3.3M ﹤0.01% 2644

Other funds holding CLB

Dimensional Fund Advisors's CLB Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Core Laboratories (CLB) stake by 10% in Q1 2026, buying an estimated $2.2M and bringing the position to 1,352,329 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Dimensional Fund Advisors first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.2M in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Dimensional Fund Advisors held 1,352,329 shares of Core Laboratories worth $22.7M as of Q1 2026.
  • Dimensional Fund Advisors bought 122,718 Core Laboratories shares in Q1 2026, an estimated $2.2M.
  • Core Laboratories made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1907 holding.
  • Dimensional Fund Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Core Laboratories position peaked at $37.2M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.